Law ❯ Securities Law

Regulatory Compliance

Investor Protection Corporate Governance FDA Regulations Enforcement Actions Disclosure Requirements SEC Securities and Exchange Commission Financial Reporting Crypto Regulations Fraudulent Practices Cryptocurrency Regulations Investigations Financial Regulations SEC Regulations Cryptocurrency Regulation Arbitration FDA Approval Disclosure Obligations Securities Exchange Act Financial Misstatements False Claims Act Litigation Investment Banking Financial Responsibility Cross-Border Transactions Nasdaq Rules Federal Trade Commission Exemptions Government Shutdowns Digital Tokens Filing Requirements Investment Regulations Public Company Regulations Investor Relations Digital Finance Crypto Custody SEC Filings Public Offerings Corporate Law Investment Contracts Private Placements Federal Agencies Securities Violations Securities Fraud Crypto Compliance Tokenized Securities Broker-Dealer Rules Ripple Labs Market Manipulation Influencer Accountability Lawsuits Investment Agreements Digital Asset Law Cryptocurrency Financial Intermediaries Investment Funds Corporate Responsibility Civil Lawsuits

CarMax Securities Suit Advances as Jan. 2 Lead‑Plaintiff Deadline Nears

Plaintiffs blame tariff‑pulled demand with elevated CarMax Auto Finance loss reserves for the 2025 share collapses.

SEC Staff Clarifies How Broker-Dealers Can Custody Crypto Securities Under Rule 15c3-3

SEC Ends Aave Probe With No Enforcement as DAO Weighs Brand Control Overhaul

Investor Firms Press Primo Brands Case as Jan. 12 Lead-Plaintiff Deadline Nears

Sprouts Farmers Market Faces Securities Class Action With Jan. 26 Lead-Plaintiff Deadline

Skye Bioscience Investors Pressed to Seek Lead Role in Securities Suit as Jan. 16 Deadline Nears

Inspire Medical Hit With Securities Class Action Over Inspire V Launch as Firms Court Lead Plaintiffs

CarMax Securities Case Expands After CEO Ouster and Weak Outlook

Savara Investors Pressed to Meet Class-Action Deadlines Over Alleged MOLBREEVI BLA Deficiencies

Cytokinetics Investors Face Nov. 17 Deadline to Seek Lead Role in Aficamten Securities Case

James Hardie Investors Face Dec. 23 Deadline To Seek Lead Role in Securities Class Action

Cytokinetics Investors Urged to Seek Counsel Before Nov. 17 Lead-Plaintiff Deadline in Aficamten Case

Cytokinetics Faces Investor Class Action Over Aficamten REMS Disclosures as Lead-Plaintiff Deadline Nears

SEC Staff Grants No-Action Relief for DoubleZero’s 2Z Token Distribution

SelectQuote Investors Face Oct. 10 Deadline in Securities Suit After DOJ Kickback Allegations

SEC Sues Buyers of RadioShack and Pier 1 Over Alleged $112 Million Investor Fraud

SEC Says IPO Arbitration Clauses Won't Hinder Registration Acceleration

Semnur Goes Public via Denali SPAC, Unveils $100 Million Bitcoin Stock Sale Plan

SEC Says Arbitration Clauses Won’t Block IPO Acceleration, Ends Automatic Stays on Challenges

SEC and Gemini Reach Tentative Settlement in Earn Case